UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance

International journal of hematology, 2022, Vol.115 (1), p.21-32

2022

Volltextzugriff (PDF)

Companion gene mutations and their clinical significance in AML with double or single mutant CEBPA

International journal of hematology, 2022-07, Vol.116 (1), p.71-80

2022

Volltextzugriff (PDF)

Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial

Journal of hematology and oncology, 2024-09, Vol.17 (1), p.79-5, Article 79

2024

Volltextzugriff (PDF)

Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines

Frontiers in oncology, 2024, Vol.14, p.1357996-1357996

2024

Volltextzugriff (PDF)

Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells

Oncotarget, 2017-12, Vol.8 (65), p.108880-108889

2017

Volltextzugriff (PDF)

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial

BMC cancer, 2023-10, Vol.23 (1), p.1-980, Article 980

2023

Volltextzugriff (PDF)

Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia

Hematology (Luxembourg), 2022-12, Vol.27 (1), p.994-1002

2022

Volltextzugriff (PDF)

Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality

Hematology (Luxembourg), 2022-12, Vol.27 (1), p.565-574

2022

Volltextzugriff (PDF)

Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell‐mediated cytolysis

Cancer science, 2010-03, Vol.101 (3), p.609-615

2010

Volltextzugriff (PDF)

Clinicopathological characteristics, prognostic factors, and outcomes of elderly patients with lymphoma‐associated hemophagocytic lymphohistiocytosis: A multicenter analysis

Cancer medicine (Malden, MA), 2024-08, Vol.13 (16), p.e70178-n/a

2024

Volltextzugriff (PDF)

High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study

Blood cancer journal (New York), 2022-10, Vol.12 (10), p.145-145, Article 145

2022

Volltextzugriff (PDF)

STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2 cells

International journal of hematology, 2015-11, Vol.102 (5), p.536-543

2015

Volltextzugriff (PDF)

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group

Heliyon, 2023-04, Vol.9 (4), p.e14924-e14924, Article e14924

2023

Volltextzugriff (PDF)

Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia

Blood, 2007-03, Vol.109 (6), p.2514-2520

2007

Volltextzugriff (PDF)

Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells

Cancer biology & therapy, 2012-06, Vol.13 (8), p.623-629

2012

Volltextzugriff (PDF)

Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma

International immunopharmacology, 2021-09, Vol.98, p.107829, Article 107829

2021

Volltextzugriff (PDF)

Selectively and Efficiently Expanding Natural Killer Cells in Vitro

Blood, 2020-11, Vol.136 (Supplement 1), p.20-20

2020

Volltextzugriff (PDF)

Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation

Blood, 2008-09, Vol.112 (5), p.2160-2162

2008

Volltextzugriff (PDF)

Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria–type cells

Blood, 2004-10, Vol.104 (8), p.2425-2431

2004

Volltextzugriff (PDF)

Reduced-Dose Chemotherapy Followed By Blinatumomab As Induction Therapy in Treatment of Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia - Interim Results from a Multicenter, Single-Arm, Phase 2 Study

Blood, 2023-11, Vol.142 (Supplement 1), p.4243-4243

2023

Volltextzugriff (PDF)

Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia

Annals of hematology, 2010-12, Vol.89 (12), p.1255-1263

2010

Volltextzugriff (PDF)

MM-SZ01 Study: A Prospective, Randomized, Controlled, Multicenter Phase III Clinical Study Which Compared Polyethylene Glycol Liposomal Doxorubicin Versus Doxorubicin Combined with Bortezomib and Dexamethasone (PDD regimen vs PAD regimen) in the Treatment of Newly Diagnosed Multiple Myeloma in China

Blood, 2022-11, Vol.140 (Supplement 1), p.12614-12615

2022

Volltextzugriff (PDF)

Predicting Treatment Response and Survival of Multiple Myeloma with the Xbp-1 Co-Expression Gene Module

Blood, 2018-11, Vol.132 (Supplement 1), p.5590-5590

2018

Volltextzugriff (PDF)

Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients

International journal of laboratory hematology, 2023-12, Vol.45 (6), p.899-907

2023

Volltextzugriff (PDF)

P-292 Clinical Characteristics and Prognostic Factors of Patients With Solitary Plasmacytoma: A Multicenter Retrospective Study

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S204-S204

2024

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(78)
Tagungsberichte
(1)

Sprache

Englisch
(69)
Chinesisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance

Companion gene mutations and their clinical significance in AML with double or single mutant CEBPA

Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial

Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines

Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial

Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia

Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality

Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell‐mediated cytolysis

Clinicopathological characteristics, prognostic factors, and outcomes of elderly patients with lymphoma‐associated hemophagocytic lymphohistiocytosis: A multicenter analysis

High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study

STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2 cells

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group

Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia

Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells

Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma

Selectively and Efficiently Expanding Natural Killer Cells in Vitro

Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation

Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria–type cells

Reduced-Dose Chemotherapy Followed By Blinatumomab As Induction Therapy in Treatment of Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia - Interim Results from a Multicenter, Single-Arm, Phase 2 Study

Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia

MM-SZ01 Study: A Prospective, Randomized, Controlled, Multicenter Phase III Clinical Study Which Compared Polyethylene Glycol Liposomal Doxorubicin Versus Doxorubicin Combined with Bortezomib and Dexamethasone (PDD regimen vs PAD regimen) in the Treatment of Newly Diagnosed Multiple Myeloma in China

Predicting Treatment Response and Survival of Multiple Myeloma with the Xbp-1 Co-Expression Gene Module

Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients

P-292 Clinical Characteristics and Prognostic Factors of Patients With Solitary Plasmacytoma: A Multicenter Retrospective Study

Suchergebnisse filtern